Monday
Demant, Sonova gain ground at Veterans Affairs in June – GN and Sivantos lag behind
Bavarian Nordic upgrades again following new batch of monkeypox contracts
Vertex doubles down on diabetes – acquires firm and resumes stem cell study
Tuesday
Abbvie to submit Genmab-developed cancer drug for EMA approval
Novartis beats sales expectations for Genmab-developed Kesimpta
Bavarian Nordic gets new order for 1.5 million monkeypox vaccine doses
Leo Pharma on leaving 22 markets: Freeing up resources enables us to invest in unmet drug needs
Boehringer Ingelheim makes million-euro investment in fight against antibiotic resistance
Johnson & Johnson’s Darzalex Q2 sales surpass projections
Wednesday
Biomarin’s hemophilia gene therapy nears European market after US setback
Thursday
Roche reports continued strong demand across portfolio in H1 2022
Roche to reshuffle management and board
Nestlé Health Science partners with Enterome to treat food allergies and bowel inflammation
Friday
CHMP officially recommends Bavarian Nordic’s vaccine for monkeypox in Europe
Amazon to acquire One Medical in USD 3.5bn deal
Audientes to launch new product in Q4
LEGO owner invests USD 40m in skin treatments from fish skin
Bavarian Nordic expects imminent European monkeypox green light
More from MedWatch
ALK to exit Turkish market: "It's bad business if all we get is peanuts"
A number of conditions made it unfeasible for the Danish allergy firm to do business in Türkiye, says CEO Carsten Hellmann. Under a calculated and ruthless strategy to focus on markets with momentum, efforts in Italy and Spain have also been reduced.
Genmab postpones crucial cancer candidate decision following Abbvie exit
For the rest of 2022, the Danish biotech firm will share all expenses relating to the development of Duohexabody-CD37 with Abbvie, despite the US-based firm’s decision to withdraw from the collaboration in question.
Genmab says new arbitration builds on a straightforward question
”I think this is a much simpler case than the first arbitration,” says Genmab CEO Jan van de Winkel on the new legal suit brought against Janssen, which stems from a fight Genmab has already lost once.
Top news from MedWatch this week
Miss anything?
Analyst: Upgraded ALK sales guidance could still be beaten
Despite an upgrade, ALK may still beat its own sales guidance, one Sydbank analyst predicts.
Senior Evidence Generation Manager 
GMP Compliance Consultant for Eltronic in Ballerup 
Director Regulatory Affairs 
Lead Auditor – Senior Quality Assurance Specialist 
Antibody Engineering Scientist 
Clinical Project/Trial Manager, Synklino 
Scientist Radiochemistry 
Senior Electronics Engineer 
Clinical Biometrics Oversight Lead 
Clinical Project Leader/ Sr. Clinical Trial Manager – make a difference and join our mission to bring our IL-22 lead program to patients 
Quality coordinator for Aseptic Production, ALK 
Global Quality Director (Business Unit Quality Lead) 
Clinical Trial Manager - Black Swans Exist 
Open position for a Clinical Trial Manager to join our team at Nykode! 
Senior Clinical Trial Manager - Black Swans Exist